Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

rhIGF-I + insulin combination tested in adolescents with IDDM

Nov. 19, 1997

No Comments

Schering-Plough obtains rights to Vasomax

Nov. 18, 1997

No Comments

SomatoKine shows potential for the treatment of osteoporosis

Nov. 18, 1997

No Comments

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

No Comments

Roche resubmits NDA for Xenical

Nov. 17, 1997

No Comments

New guidelines for patients exposed to fenfluramine or dexfenfluramine

Nov. 17, 1997

No Comments

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Nov. 17, 1997

No Comments

Novo Nordisk files for HRT product in U.S.

Nov. 13, 1997

No Comments

Alendronate and etidronate prevent steroid-induced osteoporosis

Nov. 13, 1997

No Comments

ACAT inhibitors described by Sankyo in patent literature

Nov. 13, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

rhIGF-I + insulin combination tested in adolescents with IDDM

Schering-Plough obtains rights to Vasomax

SomatoKine shows potential for the treatment of osteoporosis

Pharmacokinetic profile of Taisho's ACAT inhibitor

Roche resubmits NDA for Xenical

New guidelines for patients exposed to fenfluramine or dexfenfluramine

Antiatherosclerotic activity of Roche's benzodiazepine derivative Ro-11-1464 described

Novo Nordisk files for HRT product in U.S.

Alendronate and etidronate prevent steroid-induced osteoporosis

ACAT inhibitors described by Sankyo in patent literature

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Endocrine/metabolic RSS

Endocrine/metabolic
RSS